Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2003 Jun 7;326(7401):1247-50.
doi: 10.1136/bmj.326.7401.1247.

Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses

Peter Bower  1 , Sarah Byford, Julie Barber, Jennifer Beecham, Sharon Simpson, Karin Friedli, Roslyn Corney, Michael King, Ian Harvey
Affiliations
Meta-Analysis

Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses

Peter Bower et al. BMJ. .

Abstract

Objective: To assess the feasibility of overcoming sample size limitations in economic analyses of clinical trials through meta-analysis of data on individual patients from multiple trials.

Design: Meta-analysis of individual patient data from trials of counselling in primary care compared with usual care by a general practitioner.

Setting: Primary care.

Patients: People with mental health problems.

Main outcome measures: Direct treatment costs, depressive symptoms, and cost effectiveness.

Results: Meta-analysis of individual patient data proved feasible. The results showed that the previous analyses of individual trials were underpowered to provide useful conclusions about the cost comparisons. The results are sensitive to assumptions made about the costs of sessions with a counsellor and the management of patients by a general practitioner.

Conclusions: Meta-analysis of individual patient data may assist in overcoming sample size limitations in economic analyses. Although feasible, such analysis has shortcomings that may limit the validity of the results. The relative costs and benefits of this method, as opposed to further collection of primary data, are as yet unclear.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Data available for analyses
Fig 2
Fig 2
Total direct costs (£) over the long term
Fig 3
Fig 3
Total direct costs (£) over the short term
Fig 4
Fig 4
Cost effectiveness acceptability curve long term
See this image and copyright information in PMC

Comment in

References

    1. Lave J, Schulberg H. Integrating cost-effectiveness analyses within clinical trials of treatment for major depression in primary-care practice. In: Miller N, Magruder K, eds. Cost-effectiveness of psychotherapy: a guide for practitioners, researchers and policy makers. New York: Oxford University Press, 1999; 75-84.
    1. Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000;321: 1362-3. - PMC - PubMed
    1. Johnston K, Buxton M, Jones D, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999;3(6). - PubMed
    1. King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technol Assess 2000;4(19). - PubMed
    1. Friedli K, King M, Lloyd M. The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. Br J Gen Pract 2000;50: 276-83. - PMC - PubMed

Publication types